AICD Generator Procedures DRG 245: Reimbursement Guide

Acute perioperative device safety and implantation technique studies: randomized or observational studies assessing immediate and early complications of implantable cardioverter-defibrillator (AICD) generator procedures, such as pocket hematoma, lead dislodgement, infection, and peri‑procedural arrhythmias. These studies enroll patients undergoing generator replacement or initial generator implantation, often stratified by anticoagulation status, presence of cardiac resynchronization therapy leads, or prior device infection. Results inform procedural protocols, perioperative management, and short‑term resource utilization, which are directly relevant to inpatient clinicians and payers focused on reducing complications, readmissions, and costly reinterventions.
Comparative effectiveness research on device programming and generator selection in high‑risk subgroups: pragmatic trials or cohort studies comparing different generator models, battery longevity strategies, or programming algorithms (e.g., shock thresholds, detection intervals) in populations such as elderly patients, those with heart failure, or patients with prior shocks. These studies examine outcomes like inappropriate shocks, device longevity, quality of life, and downstream healthcare utilization over months to years after implantation. Findings guide clinicians and payers in selecting devices and programming strategies that balance upfront device cost against long‑term outcomes, replacement frequency, and total cost of care for patients classified under this DRG.
Post‑discharge outcomes and care‑coordination interventions to reduce readmissions and infections: pragmatic studies testing discharge protocols, remote monitoring programs, antibiotic stewardship around generator replacement, or structured wound care follow‑up in patients after AICD generator procedures. These trials typically focus on transition‑of‑care populations with comorbidities such as diabetes, renal disease, or anticoagulation therapy that increase post‑procedural risk. Evidence from these studies helps hospitals and payers design care pathways that lower readmission rates, reduce post‑operative infections, and optimize resource allocation for this inpatient population.

Acute perioperative device safety and implantation technique studies: randomized or observational studies assessing immediate and early complications of implantable cardioverter-defibrillator (AICD) generator procedures, such as pocket hematoma, lead dislodgement, infection, and peri‑procedural arrhythmias. These studies enroll patients undergoing generator replacement or initial generator implantation, often stratified by anticoagulation status, presence of cardiac resynchronization therapy leads, or prior device infection. Results inform procedural protocols, perioperative management, and short‑term resource utilization, which are directly relevant to inpatient clinicians and payers focused on reducing complications, readmissions, and costly reinterventions.
Comparative effectiveness research on device programming and generator selection in high‑risk subgroups: pragmatic trials or cohort studies comparing different generator models, battery longevity strategies, or programming algorithms (e.g., shock thresholds, detection intervals) in populations such as elderly patients, those with heart failure, or patients with prior shocks. These studies examine outcomes like inappropriate shocks, device longevity, quality of life, and downstream healthcare utilization over months to years after implantation. Findings guide clinicians and payers in selecting devices and programming strategies that balance upfront device cost against long‑term outcomes, replacement frequency, and total cost of care for patients classified under this DRG.
Post‑discharge outcomes and care‑coordination interventions to reduce readmissions and infections: pragmatic studies testing discharge protocols, remote monitoring programs, antibiotic stewardship around generator replacement, or structured wound care follow‑up in patients after AICD generator procedures. These trials typically focus on transition‑of‑care populations with comorbidities such as diabetes, renal disease, or anticoagulation therapy that increase post‑procedural risk. Evidence from these studies helps hospitals and payers design care pathways that lower readmission rates, reduce post‑operative infections, and optimize resource allocation for this inpatient population.

OpenPayer

Summary & Overview

AICD Generator Procedures: Inpatient Reimbursement Overview

DRG 245 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes

Summary & Overview

AICD Generator Procedures: Inpatient Reimbursement Overview

DRG 245 Overview

Clinical Trials

Related Codes

What procedures are included in DRG 245?

Why does DRG 245 matter for inpatient reimbursement?

How does coding accuracy affect DRG 245 case assignment?

What clinical trial topics inform care and utilization for DRG 245 admissions?

Which patient populations are commonly enrolled in studies related to AICD generator procedures?

Clinical Trials

Related Codes

What procedures are included in DRG 245?

Why does DRG 245 matter for inpatient reimbursement?

How does coding accuracy affect DRG 245 case assignment?

What clinical trial topics inform care and utilization for DRG 245 admissions?

Which patient populations are commonly enrolled in studies related to AICD generator procedures?